Characteristics of IDH-mutant gliomas with non-canonical IDH mutation

被引:0
|
作者
L. Poetsch
C. Bronnimann
H. Loiseau
J. S. Frénel
A. Siegfried
R. Seizeur
G. Gauchotte
D. Cappellen
C. Carpentier
D. Figarella-Branger
S. Eimer
D. Meyronet
F. Ducray
机构
[1] Service d’Oncologie Médicale,Neuro
[2] CHU de Bordeaux- Hôpital Saint André,oncology Department
[3] Service de Neurochirurgie B,undefined
[4] CHU de Bordeaux - Hôpital Pellegrin,undefined
[5] EA 7435 – IMOTION (Imagerie moléculaire et thérapies innovantes en oncologie) Université de Bordeaux,undefined
[6] Institut de Cancérologie de l’Ouest,undefined
[7] Centre René Gauducheau,undefined
[8] Service de Pathologie,undefined
[9] Institut Universitaire du Cancer de Toulouse Oncopole,undefined
[10] Service de Neurochirurgie,undefined
[11] Hôpital de la Cavale Blanche,undefined
[12] CHRU de Brest,undefined
[13] Université de Brest,undefined
[14] Service d’Anatomie et Cytologie Pathologiques,undefined
[15] CRB BB-0033-00035,undefined
[16] CHRU de Nancy,undefined
[17] INSERM U1256,undefined
[18] Université de Lorraine,undefined
[19] U1035 Inserm - Biothérapie des Maladies Génétiques,undefined
[20] Inflammatoires et Cancers (BMGIC),undefined
[21] Univ. Bordeaux,undefined
[22] Service de Biologie des Tumeurs,undefined
[23] CHU de Bordeaux - Hôpital du Haut Lévêque,undefined
[24] AP-HP,undefined
[25] Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix,undefined
[26] Service de Neurologie 2-Mazarin,undefined
[27] Sorbonne Université,undefined
[28] Inserm,undefined
[29] CNRS,undefined
[30] UMR S 1127,undefined
[31] Institut du Cerveau et de la Moelle Epiniere,undefined
[32] ICM,undefined
[33] Aix-Marseille Univ,undefined
[34] APHM,undefined
[35] CNRS,undefined
[36] INP,undefined
[37] Inst Neurophysiopathol,undefined
[38] CHU Timone,undefined
[39] Service d’Anatomie Pathologique et de Neuropathologie,undefined
[40] Service de Pathologie,undefined
[41] CHU de Bordeaux,undefined
[42] Hôpital Pellegrin,undefined
[43] Centre de Recherche en Cancérologie de Lyon,undefined
[44] INSERM U1052,undefined
[45] CNRS UMR 5286,undefined
[46] Cancer Cell Plasticity department,undefined
[47] Université Claude Bernard Lyon 1,undefined
[48] Hospices Civils de Lyon,undefined
来源
Journal of Neuro-Oncology | 2021年 / 151卷
关键词
Non-canonical IDH mutant gliomas; Inherited predisposition to cancer; Infra-tentorial gliomas; Multicentric gliomas;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:279 / 286
页数:7
相关论文
共 50 条
  • [21] Epigenetic Reprogramming for Targeting IDH-Mutant Malignant Gliomas
    Park, Jong-Whi
    Turcan, Sevin
    CANCERS, 2019, 11 (10)
  • [22] TARGETING AMINO ACID METABOLIC VULNERABILITIES IN IDH-MUTANT AND IDH-WILDTYPE GLIOMAS
    Ohba, Shigeo
    Teranishi, Takao
    Hirayama, Akiyoshi
    Hitachi, Keisuke
    Yamaguchi, Hisateru
    Natsumeda, Manabu
    Tateishi, Kensuke
    Pieper, Russell
    Hirose, Yuichi
    NEURO-ONCOLOGY, 2023, 25
  • [23] Differentiating IDH-wildtype and IDH-mutant high grade gliomas with deep learning
    Hewitt, K. J.
    Loeffler, C. M. L.
    Van Treeck, M.
    Muti, H.
    Veldhuizen, G.
    Saldanha, O.
    Bejan, L.
    Millner, T.
    Brandner, S.
    Kather, J. N.
    ANNALS OF ONCOLOGY, 2023, 34 : S398 - S398
  • [24] TARGETING AMINO ACID METABOLIC VULNERABILITIES IN IDH-MUTANT AND IDH-WILDTYPE GLIOMAS
    Ohba, Shigeo
    Hirayama, Akiyoshi
    Hitachi, Keisuke
    Yamaguchi, Hisateru
    Mukherjee, Joydeep
    Pieper, Russell
    Hirose, Yuichi
    NEURO-ONCOLOGY, 2021, 23 : 209 - 210
  • [25] Clinical, pathological and genomic features of infratentorial IDH-mutant gliomas
    Wang, L.
    BRAIN PATHOLOGY, 2023, 33
  • [26] THE PROGNOSTIC IMPLICATION OF MGMT PROMOTER METHYLATION IN IDH-MUTANT GLIOMAS
    Youssef, Gilbert
    Aquilanti, Elisa
    Muzikansky, Alona
    Miller, Julie
    Vogelzang, Jayne
    Lapinskas, Emily
    Lim-Fat, Mary Jane
    Rahman, Rifaquat
    Beroukhim, Rameen
    Bi, Wenya Linda
    Chukwueke, Ugonma
    Castro, Luis Nicolas Gonzalez
    Lee, Eudocia
    McFaline-Figueroa, J. Ricardo
    Nayak, Lakshmi
    Reardon, David A.
    Ligon, Keith
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2022, 24 : 153 - 153
  • [27] Exploiting nanopore sequencing for characterization and grading of IDH-mutant gliomas
    Wongsurawat, Thidathip
    Jenjaroenpun, Piroon
    Anekwiang, Panatna
    Arigul, Tantip
    Thongrattana, Wichayapat
    Jamshidi-Parsian, Azemat
    Boysen, Gunnar
    Suriyaphol, Prapat
    Suktitipat, Bhoom
    Srirabheebhat, Prajak
    Cheunsuchon, Pornsuk
    Tanboon, Jantima
    Nookaew, Intawat
    Sathornsumetee, Sith
    BRAIN PATHOLOGY, 2024, 34 (01)
  • [28] Molecular imaging of IDH-mutant gliomas in the new era of IDH inhibitors: preparing for future challenges
    Gaia Ninatti
    Rosa Maria Moresco
    Martina Sollini
    European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 1421 - 1422
  • [29] IDH-Mutant Gliomas Differ in Distribution of Mitochondrial Genomic Alterations
    Ozduman, Koray
    Yuksel, Sirin
    Akyerli, Cemaliye
    Bilguvar, Kaya
    Ersen-Danyeli, Ayca
    Yilmaz, Engin
    Pamir, M. Necmettin
    JOURNAL OF NEUROSURGERY, 2020, 132 (04) : 84 - 84
  • [30] Molecular imaging of IDH-mutant gliomas in the new era of IDH inhibitors: preparing for future challenges
    Ninatti, Gaia
    Moresco, Rosa Maria
    Sollini, Martina
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (05) : 1421 - 1422